Extension of Comment Period for Proposed Updates to the Bright Futures Periodicity Schedule as Part of the HRSA-Supported Preventive Services Guidelines for Infants, Children, and Adolescents, 57868-57869 [2020-20380]

Download as PDF jbell on DSKJLSW7X2PROD with NOTICES 57868 Federal Register / Vol. 85, No. 180 / Wednesday, September 16, 2020 / Notices slide presentations with audio components to allow the presentation of materials in a manner that most closely resembles an in-person advisory committee meeting. Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person on or before October 9, 2020. Oral presentations from the public will be scheduled on October 27, 2020, between approximately 1 p.m. Eastern Time and 2 p.m. Eastern Time. Those individuals interested in making formal oral presentations should notify the contact person (see FOR FURTHER INFORMATION CONTACT). The notification should include a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before October 1, 2020. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by October 2, 2020. For press inquiries, please contact the Office of Media Affairs at fdaoma@ fda.hhs.gov or 301–796–4540. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with disabilities. If you require accommodations due to a disability, please contact AnnMarie Williams at Annmarie.Williams@ fda.hhs.gov or 301–796–5966 at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our website at https://www.fda.gov/ AdvisoryCommittees/ AboutAdvisoryCommittees/ ucm111462.htm for procedures on public conduct during advisory committee meetings. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). Dated: September 11, 2020. Lauren K. Roth, Associate Commissioner for Policy. [FR Doc. 2020–20446 Filed 9–15–20; 8:45 am] BILLING CODE 4164–01–P VerDate Sep<11>2014 18:20 Sep 15, 2020 Jkt 250001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Extension of Comment Period for Proposed Updates to the Bright Futures Periodicity Schedule as Part of the HRSA-Supported Preventive Services Guidelines for Infants, Children, and Adolescents Health Resources and Services Administration (HRSA), Department of Health and Human Services. ACTION: Notice. AGENCY: HRSA is providing notice of a technical issue in the collection of public comments responding to a previous Federal Register notice, dated August 20, 2020, submitted to the American Academy of Pediatrics through its publicly available web-based portal during the period from August 20–27, 2020. After receiving no comments during this timeframe, a routine test found that the database that records public comments was not connected to the comment form on the web page. This technical issue has been resolved and the system is functional and collecting comments. HRSA encourages members of the public who may have previous submitted comments to resubmit and is extending the time period for public comments in response to proposed updates to the Periodicity Schedule of the Bright Futures Recommendations for Pediatric Preventive Health Care (‘‘Bright Futures Periodicity Schedule’’). The Bright Futures Periodicity Schedule is part of the HRSA-supported preventive service guidelines for infants, children, and adolescents under, and is maintained, in part, through a national cooperative agreement, the Bright Futures Pediatric Implementation Program. DATES: The comment period published in the Federal Register on August 20, 2020, at 85 FR 51454–01 is extended. Members of the public are invited to provide written comments no later than October 16, 2020. All comments received on or before this date will be reviewed and considered by the Bright Futures Periodicity Schedule Workgroup and provided for further consideration by HRSA in determining the recommended updates that it will support. ADDRESSES: Members of the public interested in providing comments can do so by accessing the public comment web page at: https://mchb.hrsa.gov/ maternal-child-health-topics/childhealth/bright-futures.html. SUMMARY: PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 FOR FURTHER INFORMATION CONTACT: Bethany Miller, HRSA, Maternal and Child Health Bureau, email: BMiller@ hrsa.gov, telephone: (301) 945–5156. SUPPLEMENTARY INFORMATION: On August 20, 2020, HRSA published a notice soliciting public comments regarding proposed updates to the Bright Futures Periodicity Schedule (85 FR 51454–01). Due to technical issues, comments that may have been submitted between August 20, 2020, and August 27, 2020, were not captured. To ensure that all comments are received and considered, the public is encouraged to resubmit any comments that were provided in response to the notice published on August 20, 2020 (85 FR 51454–01) and also is extending the time period for public comments. HRSA has funded the Bright Futures Program as a cooperative agreement since 1990. A primary focus of this program is for the funding recipient to maintain and update the Bright Futures Guidelines for Health Supervision of Infants, Children and Adolescents, a set of materials and tools for providing quality preventive care screenings and well-child visits. One component of these tools is the Bright Futures Periodicity Schedule, a chart that identifies the recommended screenings, assessments, physical examinations, and procedures to be delivered within preventive checkups at each age milestone. Over the program’s existence, the Bright Futures Periodicity Schedule has become the accepted schedule within the United States for preventive health services through the course of a child’s development. Under section 2713 of the Public Health Service Act, 42 U.S.C. 300gg–13, non-grandfathered group health plans and health insurance issuers must include coverage, without cost sharing, for certain preventive services, for plan years (in the individual market, policy years) that begin on or after the date that is one year after the date the recommendation or guideline is issued. These include preventive health services provided for in the Bright Futures Periodicity Schedule as part of the HRSA-supported Preventive Services Guidelines for Infants, Children, and Adolescents. A panel of pediatric primary care experts convened to review the latest evidence and recommends updating the Bright Futures Periodicity Schedule to include screening all individuals ages 18 and older at least once for hepatitis C virus infection. This proposed update aligns with the United States Preventive Services Task Force’s recommendation that all adults ages 18 to 79 be screened E:\FR\FM\16SEN1.SGM 16SEN1 Federal Register / Vol. 85, No. 180 / Wednesday, September 16, 2020 / Notices at least once for hepatitis C virus infection. The American Academy of Pediatrics, which has been the HRSA cooperative agreement recipient for this program since 2007, maintains the Periodicity Schedule. Under HRSA’s cooperative agreement with the American Academy of Pediatrics, the Bright Futures Program is required to administer a process for developing and regularly recommending, as needed, updates to the Bright Futures Periodicity Schedule. As described in the Notice of Funding Opportunity for the Bright Futures Program (HRSA–18–078), the consideration of potential updates is expected to be ‘‘a comprehensive, objective, and transparent review of available evidence that incorporates opportunity for public comment.’’ Thomas J. Engels, Administrator. [FR Doc. 2020–20380 Filed 9–15–20; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Meeting of the National Advisory Council on Migrant Health Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: In accordance with the Federal Advisory Committee Act, this notice announces that the Secretary’s National Advisory Council on Migrant Health (NACMH or Council) has scheduled a public meeting. Information about NACMH and the agenda for this meeting can be found on the NACMH website at: https://bphc.hrsa.gov/ qualityimprovement/ strategicpartnerships/nacmh. DATES: October 20–23, 2020; 1:00 p.m. to 5:00 p.m. Eastern Time (ET). ADDRESSES: This meeting will be held by webinar. Instructions for joining the meetings will be posted on the NACMH website 30 calendar days before the date of the meeting. For meeting information updates, go to the NACMH website at: https://bphc.hrsa.gov/ qualityimprovement/ strategicpartnerships/nacmh. FOR FURTHER INFORMATION CONTACT: Esther Paul, NACMH Designated Federal Officer (DFO), Strategic Initiatives and Planning Division, Office of Policy and Program Development, jbell on DSKJLSW7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:20 Sep 15, 2020 Jkt 250001 57869 Bureau of Primary Health Care, HRSA, 5600 Fishers Lane, Rockville, Maryland 20857; 301–594–4300; or epaul@ hrsa.gov. DEPARTMENT OF HEALTH AND HUMAN SERVICES NACMH advises, consults with, and makes recommendations to the Secretary of HHS on policy, program development, and other matters of significance concerning the activities under section 217 of the Public Health Service (PHS) Act, as amended (42 U.S.C. 218). Specifically, NACMH provides recommendations concerning policy related to the organization, operation, selection, and funding of migrant health centers, and other entities under grants and contracts under section 330 of the PHS Act (42 U.S.C. 254b). NACMH meets twice each calendar year, or at the discretion of the DFO in consultation with the NACMH Chair. Since priorities dictate meeting times, be advised that times and agenda items are subject to change. The agenda items for the meeting may include, but are not limited to, topics and issues related to migratory and seasonal agricultural worker health. Refer to the NACMH website listed above for all current and updated information concerning the October 2020 NACMH meeting, including draft agenda and meeting materials that will be posted 30 calendar days before the meeting. Members of the public will have the opportunity to provide comments. Public participants may submit written statements in advance of the scheduled meeting. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to submit a written statement or make oral comments to the NACMH meeting should be sent to Esther Paul using the contact information above at least 5 business days before the meeting. Individuals who need special assistance or another reasonable accommodation should notify Esther Paul using the contact information listed above at least 10 business days before the meeting. All attendees are required to register to attend the meeting prior to entry. Instructions for how to register and join will be posted on the NACMH website 30 calendar days before the meeting. Submission for OMB Review; 30-Day Comment Request; Bench to Bedside: Integrating Sex and Gender To Improve Human Health & Sex as a Biological Variable: A Primer (Office of the Director) SUPPLEMENTARY INFORMATION: Maria G. Button, Director, Executive Secretariat. [FR Doc. 2020–20420 Filed 9–15–20; 8:45 am] BILLING CODE 4165–15–P PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 National Institutes of Health AGENCY: National Institutes of Health, HHS. ACTION: Notice. In compliance with the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. DATES: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication. SUMMARY: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Dr. Chyren Hunter, Associate Director, Basic and Translational Research, Office of Research on Women’s Health, 6707 Democracy Blvd., Room 437, Bethesda, Maryland 20817 or call non-toll-free number (301) 496–7849 or email your request to ORWHCourses@od.nih.gov. SUPPLEMENTARY INFORMATION: This proposed information collection was previously published in the Federal Register on April 30, 2020, pages 23978–23980 and allowed 60 days for public comment. One comment was received. The purpose of this notice is to allow an additional 30 days for public comment. The Office of Research on Women’s Health, National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. ADDRESSES: E:\FR\FM\16SEN1.SGM 16SEN1

Agencies

[Federal Register Volume 85, Number 180 (Wednesday, September 16, 2020)]
[Notices]
[Pages 57868-57869]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-20380]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Extension of Comment Period for Proposed Updates to the Bright 
Futures Periodicity Schedule as Part of the HRSA-Supported Preventive 
Services Guidelines for Infants, Children, and Adolescents

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: HRSA is providing notice of a technical issue in the 
collection of public comments responding to a previous Federal Register 
notice, dated August 20, 2020, submitted to the American Academy of 
Pediatrics through its publicly available web-based portal during the 
period from August 20-27, 2020. After receiving no comments during this 
timeframe, a routine test found that the database that records public 
comments was not connected to the comment form on the web page. This 
technical issue has been resolved and the system is functional and 
collecting comments. HRSA encourages members of the public who may have 
previous submitted comments to resubmit and is extending the time 
period for public comments in response to proposed updates to the 
Periodicity Schedule of the Bright Futures Recommendations for 
Pediatric Preventive Health Care (``Bright Futures Periodicity 
Schedule''). The Bright Futures Periodicity Schedule is part of the 
HRSA-supported preventive service guidelines for infants, children, and 
adolescents under, and is maintained, in part, through a national 
cooperative agreement, the Bright Futures Pediatric Implementation 
Program.

DATES: The comment period published in the Federal Register on August 
20, 2020, at 85 FR 51454-01 is extended. Members of the public are 
invited to provide written comments no later than October 16, 2020. All 
comments received on or before this date will be reviewed and 
considered by the Bright Futures Periodicity Schedule Workgroup and 
provided for further consideration by HRSA in determining the 
recommended updates that it will support.

ADDRESSES: Members of the public interested in providing comments can 
do so by accessing the public comment web page at: https://mchb.hrsa.gov/maternal-child-health-topics/child-health/bright-futures.html.

FOR FURTHER INFORMATION CONTACT: Bethany Miller, HRSA, Maternal and 
Child Health Bureau, email: [email protected], telephone: (301) 945-
5156.

SUPPLEMENTARY INFORMATION:  On August 20, 2020, HRSA published a notice 
soliciting public comments regarding proposed updates to the Bright 
Futures Periodicity Schedule (85 FR 51454-01). Due to technical issues, 
comments that may have been submitted between August 20, 2020, and 
August 27, 2020, were not captured. To ensure that all comments are 
received and considered, the public is encouraged to resubmit any 
comments that were provided in response to the notice published on 
August 20, 2020 (85 FR 51454-01) and also is extending the time period 
for public comments.
    HRSA has funded the Bright Futures Program as a cooperative 
agreement since 1990. A primary focus of this program is for the 
funding recipient to maintain and update the Bright Futures Guidelines 
for Health Supervision of Infants, Children and Adolescents, a set of 
materials and tools for providing quality preventive care screenings 
and well-child visits. One component of these tools is the Bright 
Futures Periodicity Schedule, a chart that identifies the recommended 
screenings, assessments, physical examinations, and procedures to be 
delivered within preventive checkups at each age milestone. Over the 
program's existence, the Bright Futures Periodicity Schedule has become 
the accepted schedule within the United States for preventive health 
services through the course of a child's development.
    Under section 2713 of the Public Health Service Act, 42 U.S.C. 
300gg-13, non-grandfathered group health plans and health insurance 
issuers must include coverage, without cost sharing, for certain 
preventive services, for plan years (in the individual market, policy 
years) that begin on or after the date that is one year after the date 
the recommendation or guideline is issued. These include preventive 
health services provided for in the Bright Futures Periodicity Schedule 
as part of the HRSA-supported Preventive Services Guidelines for 
Infants, Children, and Adolescents. A panel of pediatric primary care 
experts convened to review the latest evidence and recommends updating 
the Bright Futures Periodicity Schedule to include screening all 
individuals ages 18 and older at least once for hepatitis C virus 
infection. This proposed update aligns with the United States 
Preventive Services Task Force's recommendation that all adults ages 18 
to 79 be screened

[[Page 57869]]

at least once for hepatitis C virus infection.
    The American Academy of Pediatrics, which has been the HRSA 
cooperative agreement recipient for this program since 2007, maintains 
the Periodicity Schedule. Under HRSA's cooperative agreement with the 
American Academy of Pediatrics, the Bright Futures Program is required 
to administer a process for developing and regularly recommending, as 
needed, updates to the Bright Futures Periodicity Schedule. As 
described in the Notice of Funding Opportunity for the Bright Futures 
Program (HRSA-18-078), the consideration of potential updates is 
expected to be ``a comprehensive, objective, and transparent review of 
available evidence that incorporates opportunity for public comment.''

Thomas J. Engels,
Administrator.
[FR Doc. 2020-20380 Filed 9-15-20; 8:45 am]
BILLING CODE 4165-15-P